You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 27, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Hongxiang Li1, Zehong Qiu2, Jing Zhang1
1Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
A new deep learning model using intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) shows promise for predicting early recurrence in hepatocellular carcinoma (HCC). The combined model demonstrated superior accuracy, potentially guiding personalized postoperative monitoring for HCC patients.
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: